Amgen Inc
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Puerto Rico Plan by Year
Puerto Rico Plan — Amgen Inc. Common Stock Held in Plan ($M) ($M)
Amgen Puerto Rico Plan: $101M in FY2025, down 10.7% from a year earlier.
Latest, FY2025
101
Period ended Dec 31, 2025
Change on a year earlier
-10.7%
113 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| Amgen stock | $ | 100,973,506 | $ | — | $ | — | $ | 100,973,506”
Source: Form 11-K (Retirement & Savings Plan) (amgn-20260611.htm, filed 2026-06-11) ↗
Reported in Form 11-K Retirement and Savings Plan for Amgen Manufacturing Limited (Puerto Rico).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Amgen Puerto Rico Plan ($M), annual FY2017–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/plan-pr-amgn-stock
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.